T98G

T98G is a glioblastoma cell line used in brain cancer research and drug development.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

T98G is a glioblastoma cell line used in brain cancer research and drug development. The T98G cell line was derived from a 61-year-old human male and has a hyper pentaploid chromosome count with a modal number ranging from 128 to 132. The cells are not tumorigenic in mice but do proliferate with proper anchorage in cell culture.

T98G cells are known for having high expression of the ACTA2 gene, which is involved in cell motility and structure. T98G cells are polyploidy variants of the parent T98 cell line, and can stay in the G1 phase of the cell cycle under stationary conditions.

T98G cells have been investigated along with A172 cells for drug cytotoxicity, and were found to be resistant to cisplatin, with larger cytotoxic effects induced by viral-mediated production of the p53 protein.

Cellosaurus entry for T98G

Text derived from https://en.wikipedia.org/w/index.php?oldid=1326003589 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001326003589 · captured 1765026550.0 · version history

Cite this page as: encyclopegia.org, “T98G”, snapshot enwiki-001326003589. https://encyclopegia.org/a/t98g

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.